{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:21:49Z","timestamp":1780327309899,"version":"3.54.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":2159,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To retrieve and assess the available data in the literature about the safety and efficacy of baroreflex activation therapy (BAT) in heart failure with reduced ejection fraction (HFrEF) patients, through a rapid systematic review of clinical studies. Rapid systematic review of literature. Searched electronic databases included PubMed, EMBASE, CENTRAL, Scopus, and Web of Science using Mesh and free terms for heart failure and BAT. No language restriction was used for the searches. We included full peer reviewed publications of clinical studies (randomized or not), including patients with HFrEF undergoing BAT, with or without control group, assessing safety and efficacy outcomes. One reviewer conducted the analysis of the selected abstracts and the full-text articles, performed data extraction, and evaluated the methodological quality of the selected articles. The methodological quality was assessed according to the Cochrane Collaboration instruments. A descriptive summary of the results is provided. Of the 441 citations screened, 10 publications were included (three were only conference abstracts), reporting data from three studies. Only one study was a randomized clinical trial. Two studies reported a 6 month following, and the other study analysed outcomes up to 41 months. The procedure seems to be safe when performed by a well-trained multi-professional team. An 86% rate of system and procedure-related complication-free was reported, with no cranial nerve injuries. Improvements in New York Heart Association class of heart failure, quality of life, 6 min walk test, and hospitalization rates, as well as in muscle sympathetic nerve activity. No meta-analysis was conducted because of the lack of homogeneity across studies; the results from each study are reported individually. BAT procedure seems to be safe if appropriate training is provided. Improvements in clinical outcomes were described in all included studies. However, several limitations do not allow us to make conclusive statements on the efficacy of BAT for HFrEF. New well-designed trials are still needed.<\/jats:p>","DOI":"10.1002\/ehf2.12543","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T01:28:10Z","timestamp":1579656490000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and Efficacy of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction: A Rapid Systematic Review"],"prefix":"10.1093","volume":"7","author":[{"given":"Rodrigo","family":"Schmidt","sequence":"first","affiliation":[{"name":"Heart Institute (InCor), Medical School, University of Sao Paulo , Sao Paulo ,","place":["Brazil"]},{"name":"Institute for Neuro-Immune Medicine, Nova Southeastern University , Fort Lauderdale, FL ,","place":["USA"]},{"name":"Miami Veterans Affairs Healthcare System , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Garcia","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Global Research and Innovation Network (GRINN) , Joinville, Santa Catarina ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelen Heinrich","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Nova Southeastern University , Fort Lauderdale, FL , , (W.O.C.)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Claudia Costa","family":"Irigoyen","sequence":"additional","affiliation":[{"name":"Heart Institute (InCor), Medical School, University of Sao Paulo , Sao Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"2026012115054821900_ehf212543-bib-0001","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"2026012115054821900_ehf212543-bib-0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115054821900_ehf212543-bib-0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11897-016-0286-8","article-title":"Baroreflex activation therapy in heart failure with reduced ejection fraction: available data and future perspective","volume":"13","author":"Halbach","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"2026012115054821900_ehf212543-bib-0004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system activation in human heart failure: clinical implications of an updated model","volume":"54","author":"Floras","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012115054821900_ehf212543-bib-0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.semtcvs.2016.08.009","article-title":"Baroreflex activation therapy for patients with heart failure and low ejection fraction is safe and effective","volume":"28","author":"Ad","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2026012115054821900_ehf212543-bib-0006","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ejhf.138","article-title":"Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study","volume":"16","author":"Gronda","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012115054821900_ehf212543-bib-0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026012115054821900_ehf212543-bib-0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.110.955013","article-title":"Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure","volume":"4","author":"Sabbah","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012115054821900_ehf212543-bib-0009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11886-012-0265-y","article-title":"Baroreflex activation for the treatment of heart failure","volume":"14","author":"Sabbah","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"2026012115054821900_ehf212543-bib-0010","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.107.095216","article-title":"Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure","volume":"50","author":"Zucker","year":"2007","journal-title":"Hypertension"},{"key":"2026012115054821900_ehf212543-bib-0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2026012115054821900_ehf212543-bib-0012"},{"key":"2026012115054821900_ehf212543-bib-0013","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"18","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026012115054821900_ehf212543-bib-0014","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026012115054821900_ehf212543-bib-0015","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/HJH.0000000000000603","article-title":"Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction","volume":"33","author":"Gronda","year":"2015","journal-title":"J Hypertens"},{"key":"2026012115054821900_ehf212543-bib-0016","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00392-016-0992-y","article-title":"Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure","volume":"105","author":"Gronda","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026012115054821900_ehf212543-bib-0017","author":"Gronda"},{"key":"2026012115054821900_ehf212543-bib-0018","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ejhf.299","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy","volume":"17","author":"Zile","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012115054821900_ehf212543-bib-0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semtcvs.2016.04.017","article-title":"Surgical experience and long-term results of baroreflex activation therapy for heart failure with reduced ejection fraction","volume":"28","author":"Weaver","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2026012115054821900_ehf212543-bib-0020","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx502.P1475","article-title":"P1475Positive effects of baroreflex activation therapy in heart failure with reduced ejection fraction are independent of baseline blood pressure","volume":"38","author":"Wachter","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012115054821900_ehf212543-bib-0021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2018.04.075","article-title":"Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease","volume":"266","author":"Halbach","year":"2018","journal-title":"Int J Cardiol [Internet]"},{"key":"2026012115054821900_ehf212543-bib-0022","author":"Mueller-Ehmsen"},{"key":"2026012115054821900_ehf212543-bib-0023","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"2026012115054821900_ehf212543-bib-0024","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14779072.2014.979790","article-title":"Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction","volume":"12","author":"Halbach","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012115054821900_ehf212543-bib-0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10641963.2016.1273943","article-title":"Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis","volume":"40","author":"Chunbin","year":"2018","journal-title":"Clin Exp Hypertens"},{"key":"2026012115054821900_ehf212543-bib-0026","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/HYPERTENSIONAHA.108.119883","article-title":"Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives","volume":"54","author":"Grassi","year":"2009","journal-title":"Hypertension"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12543","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/1\/3\/65804448\/eschf_7_1_3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/1\/3\/65804448\/eschf_7_1_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:06:57Z","timestamp":1769026017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/1\/3\/8373167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,21]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12543","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"2019-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}